EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 27th, 2025 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledFebruary 27th, 2025 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of January 10, 2022 by and between Iovance Biotherapeutics, Inc., a Delaware corporation (the “Company”), and Raj K. Puri, M.D., Ph.D. (“Employee”) (either party individually, a “Party”; collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 27th, 2025 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledFebruary 27th, 2025 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of January 25, 2025 by and between Iovance Biotherapeutics, Inc., a Delaware corporation (the “Company”), and Daniel Gordon Kirby (“Employee”) (either party individually, a “Party”; collectively, the “Parties”).